Yao Zhang1, Shan Xu2, Ruiting Zhang1, and Peiyu Huang2
1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 2The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Synopsis
Keywords: Vessels, fMRI (resting state)
Due to
the insidious development of vascular degeneration, assessing subclinical
vascular changes in people at high risks may aid early detection and
intervention. We explored the
relationship between the subclinical vascular function changes and vascular
risks, vascular imaging markers, and cognition in a middle-to-old age community
cohort. We found that larger vascular contractility in the intracranial
arteries was related to younger age, less lacune, and better cognition.
Participants with diabetes had a longer blood transit time from the ICAs to the
capillary. These results suggested that subclinical vascular imaging markers
were associated with brain parenchymal damage and cognitive decline.
Introduction
Cerebrovascular health is crucial for maintaining
brain function during aging. Due to the insidious development of vascular
degeneration, these downstream parenchymal markers with presumed vascular origin1, 2 (white matter
hyperintensity, WMH, lacunes, etc.) might not be able to timely reflect the
state of vascular injury3. Several
new ways to explore the spontaneous low-frequency fluctuations (sLFOs,
<0.1Hz) in cerebral vasculature by functional magnetic resonance imaging (fMRI)3 may help us to understand the vascular health. SLFOs4 is originated from
the endogenous fluctuations in the vascular tone, which could travel along thecerebral vasculature. According to previous studies5, 6, the time shift of propagation
of sLFOs through the
different
vascular regions was interpreted as blood transit time, whose abnormal delay
was related to cerebral hemodynamic impairment7, 8. SLFOs signal
changes in the intracranial arteries (ICAs) were suggested to reflect vessel
volume fluctuations related to the vascular contractility5, 6. In this study, we aimed to explore these subclinical changes in vascular health
using fMRI, and to understand their associations with brain degeneration and
cognitive functions.
Methods
A total of 212 subjects were
enrolled from a prospectively collected community cohort. All subjects signed
informed consent on admission and underwent a complete assessment of cognitive
functions and multi-modality magnetic resonance imaging scans (3D T1W images,
T2W images and T2 FLAIR images, rsfMRI images, 3D arterial spin labeling (ASL)
images).
In this study, several markers (cerebral blood flow,
cerebral blood transit time, and vascular contractility in ICAs) was used to
reflect subclinical vascular function changes, and lacunes and WMH to reflect parenchymal
damages. Lacune was assessed according to the Standards for Reporting Vascular
Changes on Neuroimaging (STRIVE)9. The volume of WMH was
quantified using a deep-learning based segmentation method and then normalized
by intracranial volume (ICV). Cerebral blood flow in gray matter (GM CBF) was
calculated from ASL image by ExploreASL toolbox.
To obtain transit time from large
arteries to the venous side, bilateral ICAs and the sagittal sinus (SSS) and
were defined as our regions of interest (ROI). Consistent with previous
studies5, 6, these ROIs
were identified using T1- and T2 -weighted image, and then registered to the
fMRI image which had processed by band-pass filtering at 0.01-0.1HZ. We set the
ICAs signal as reference and calculated the maximal cross-correlation (MCCC)
and lag time between the ICAs, SSS and global mean signal over a range time
lags (-10s ~ 10s) for individuals. Above processed procedures were shown in the
Figure 1. We verified the credibility of the above cross-correlation between two
signals by permutation tests and excluded spurious correlation. In the
following-up statistical analysis, we used the absolute values of the coupling
indices for easily understanding. The result of permutation tests and the real
correlation between signals were shown in Figure2 and 3. A larger value
represents a better coupling between the two signals. To assess vascular
contractility, standard deviation of the signal series of the ICA (ICAstd_wave)
was quantified. A larger ICAstd_wave suggested a larger fluctuation
of vessel diameters.
We used the correlation analysis to
explore the relationship between the confounders (age, sex, ICV) and subclinical
vascular biomarkers (lag indices, ICAstd_wave and GM CBF). The multiple linear regression models were performed to explore the
relationship between the subclinical biomarkers and vascular risks and SVD
biomarkers when controlled for above confounds. Finally, we investigated the
correlation between all cerebrovascular healthy indictors and cognition
assessments (MMSE and MOCA) using multiple linear regression when adjusted for
age, sex and education. In all regression models, we used the variance
inflation factor (VIF) to monitor multicollinearity.
Results
We found that the contractility of the ICAs was
negatively associated with age (β = -0.150, p = 0.029). Subjects
with diabetes have significantly longer blood transit time from the ICAs to
capillary (β = 0.155, p = 0.024), controlling for age, sex and the intracranial
volume. Furthermore, subjects with larger contractility in ICAs had
a lower risk of lacunes (OR = 0.404, p = 0.02). Higher CBF in total gray matter
(β = 0.163, p = 0.009) and larger contractility (β = 0.126, p = 0.045) in ICAs
were associated with better cognition.Conclusion
The present study investigated
subclinical vascular changes in a relatively young community cohort and found
that: (1) decreased vascular contractility was associated with aging; (2)
longer blood transit time was related to the presence of diabetes; (3) subjects
with lower vascular contractility had more lacunes, controlling for vascular
risk factors; (4) lower vascular contractility and GM CBF were associated with
worse cognition. Our study demonstrated the importance of subclinical vascular
health to further parenchymal damage and cognitive function, highlighting the need
for early monitoring.
In the current study, sLFOs
signal we obtained is mixed with other confounding factors - the effects of
respiratory and cardiac beats which can’t be removed by simple filter. Further
studies are needed to discuss the correlation between this indicator and
vascular health to enhance its credibility. Additionally, due to the
cross-sectional nature of the present study, whether these subclinical markers
could predict further vascular related brain damages and cognitive decline still
need to be understood in longitudinal studies.Acknowledgements
No acknowledgement found.References
1. van Veluw SJ,
Arfanakis K, Schneider JA. Neuropathology of Vascular Brain Health: Insights
From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral
Small Vessel Disease. Stroke 2022;
53(2): 404-415.
2. Cannistraro RJ,
Badi M, Eidelman BH, Dickson DW, Middlebrooks EH, Meschia JF. CNS small vessel
disease: A clinical review. Neurology 2019;
92(24): 1146-1156.
3. Wardlaw JM, Smith
C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol 2019; 18(7): 684-696.
4. Tong Y, Hocke LM,
Frederick BB. Low Frequency Systemic Hemodynamic "Noise" in Resting
State BOLD fMRI: Characteristics, Causes, Implications, Mitigation Strategies,
and Applications. Front Neurosci 2019;
13: 787.
5. Tong Y, Yao JF,
Chen JJ, Frederick BD. The resting-state fMRI arterial signal predicts
differential blood transit time through the brain. J Cereb Blood Flow Metab 2019; 39(6): 1148-1160.
6. Yao JF, Wang JH,
Yang HS, Liang Z, Cohen-Gadol AA, Rayz VL
et al. Cerebral circulation time derived from fMRI signals in large blood
vessels. J Magn Reson Imaging 2019;
50(5): 1504-1513.
7. Amemiya S,
Kunimatsu A, Saito N, Ohtomo K. Cerebral hemodynamic impairment: assessment
with resting-state functional MR imaging. Radiology
2014; 270(2): 548-55.
8. Yan S, Qi Z, An Y,
Zhang M, Qian T, Lu J. Detecting perfusion deficit in Alzheimer's disease and
mild cognitive impairment patients by resting-state fMRI. J Magn Reson Imaging 2019; 49(4): 1099-1104.
9. Wardlaw JM, Smith
EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R et al. Neuroimaging standards for research into small vessel
disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12(8): 822-38.